Galaxy Surfactants Ltd Q1 FY26 – ₹1,278 Cr Sales, ₹79 Cr PAT, P/E 25×, Exporting Foam While Investors Drown in Bubbles
1. At a Glance
Galaxy Surfactants is the behind-the-scenes soap opera of the FMCG world — literally. The company makes surfactants, preservatives, and specialty chemicals that go into shampoos, lotions, detergents, and your favourite ₹5 sachet shampoo. With a market cap of ₹7,744 Cr, price at ₹2,184, and a P/E of 25×, the stock is trading like it’s the Ranbir Kapoor of specialty chemicals — respected, but not exactly blockbuster.
Book value stands at ₹666, so CMP is 3.3× P/B. Dividend yield? 1%. ROE at 13.5% and ROCE at 16.2% are decent, but nowhere close to chemical multibagger legends. Sales for FY25 hit ₹4,528 Cr, PAT ₹305 Cr. Yet the 1-year return is a depressing –27%. Basically, the company foams up profits, but the stock price refuses to lather.
2. Introduction
If you thought chemicals were boring, Galaxy Surfactants is here to prove you right. It was born in 1986, back when India was still watching Doordarshan and washing hair with Shikakai. Fast forward 39 years, and Galaxy is supplying to Unilever, P&G, Colgate, L’Oréal, Himalaya, Emami — basically every brand in your bathroom rack owes its foam to Galaxy.
But here’s the twist: despite supplying to 1,380+ clients across 80 countries, and being India’s largest oleo-chemicals based surfactant producer, the stock behaves like an introvert at a wedding. Five-year sales CAGR? Just 10%. PAT CAGR? 6%. Meanwhile, peers like Gujarat Fluoro and Deepak Nitrite are out there doing naagin dance on the bourses.
The company keeps shouting “innovation” with 110 patents globally, but investors keep replying, “Arre bhai, show me the money.” No wonder the share price has been sliding like soap in a wet bathroom.
3. Business Model – WTF Do They Even Do?
Okay Sherlock, let’s break it down.
Performance Surfactants (60% revenue): These are your everyday foaming and cleaning chemicals — Anionic, Non-ionic, Amphoteric, Cationic. If you’ve ever seen foam in your toothpaste or shampoo, thank Galaxy. Key molecules: FAES, FAS, LABSA, Betaines. Basically, the building blocks of “foam = clean” psychology.
Specialty Care (40% revenue): This is the “fancy” stuff — preservatives, UV filters, proteins, conditioning agents. Think anti-aging creams, sunscreen, and shampoo that promises “Keratin Complex” (read: expensive chemistry jargon).
Geography: India 40%, Africa/Middle East/Turkey (AMET) 24%, Rest of the World 36%. So yes, your African cousin also foams up using Galaxy ingredients.
Clients: Over 1,380, including MNCs (58%), regional players (12%), and local brands (30%). Translation: Galaxy is the middleman magician behind Dove, Clinic Plus, and your colony-level detergent brand.
Detective verdict? They don’t sell products directly, they sell invisibility. Consumers never see “Galaxy” on a pack — only FMCG giants know the supplier. That invisibility is both their moat and their curse.
4. Financials Overview
Here’s the Q1 FY26 Sherlock table:
Source table
Metric
Latest Qtr (Jun 25)
YoY Qtr (Jun 24)
Prev Qtr (Mar 25)
YoY %
QoQ %
Revenue (₹ Cr)
1,278
974
1,145
+31.2%
+11.6%
EBITDA (₹ Cr)
124
124
127
0.0%
–2.4%
PAT (₹ Cr)
79.5
80
76
–0.6%
+4.6%
EPS (₹)
22.4
22.5
21.4
–0.4%
+4.7%
Detective notes: Revenue zoomed, profits flat. Classic FMCG supplier problem — they pass volumes, but margins stay hostage to big client negotiations. Galaxy is basically the ITC of chemicals: consistent, but investors keep asking “bas itna hi?”
5. Valuation Discussion – Fair Value Range
P/E Method: EPS ~₹86. CMP ₹2,184 = P/E 25×. Industry peers trade at 35–60×. Fair P/E range for Galaxy (given steady but not flashy growth): 22×–30×. → ₹1,900 – ₹2,600/share.
